MARKET

GNOM

GNOM

Global X Genomics & Biotechnology ETF
NASDAQ
11.43
+0.23
+2.05%
Closed 16:00 03/27 EDT
OPEN
11.34
PREV CLOSE
11.20
HIGH
11.43
LOW
11.13
VOLUME
26.64K
TURNOVER
0
52 WEEK HIGH
13.33
52 WEEK LOW
8.63
TOTAL ASSET
103.24M
YTD YIELD
-4.12%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at GNOM last week (0318-0322)?
Weekly Report · 3d ago
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment
Global X Genomics & Biotechnology ETF invests across companies benefiting from advancements in the field of genomics within biotechnology. The fund's historical performance has been poor amid volatile stock prices for underlying holdings. Genomics may be the future, but still missing a blockbuster application to drive momentum in the segment.
Seeking Alpha · 5d ago
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 5d ago
Weekly Report: what happened at GNOM last week (0311-0315)?
Weekly Report · 03/18 11:03
2024 Outlook: A New 'Super Boom'? Or Chop And Churn?
Seeking Alpha · 03/13 14:10
Weekly Report: what happened at GNOM last week (0304-0308)?
Weekly Report · 03/11 11:00
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
Weekly Report: what happened at GNOM last week (0226-0301)?
Weekly Report · 03/04 11:03
More
Profile
Fund Name
Global X Genomics & Biotechnology ETF
Inception Date
2019-04-05
Benchmark
Solactive Genomics NR USD
Advisor Company
Global X Management Co LLC
Custodian
Bank of New York Mellon
Manager
Nam To, Wayne Xie, Kimberly Chan, Vanessa Yang, Sandy Lu, William Helm